Spatial Transcriptomics Analysis Reveals that CCL17 and CCL22 are Robust Indicators of a Suppressive Immune Environment in Angioimmunoblastic T Cell Lymphoma (AITL)
Background: T cell lymphoma is a complex and highly aggressive clinicopathological entity with a poor outcome. The angioimmunoblastic T-cell lymphoma (AITL) tumor immune microenvironment is poorly investigated. Methods: Here, to the best of our knowledge, spatial transcriptomics was applied for the...
Main Authors: | Jun Du, Chen Qiu, Wei-Song Li, Bing Wang, Xin-Le Han, Su-Wen Lin, Xue-Hang Fu, Jian Hou, Zou-Fang Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-09-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/27/9/10.31083/j.fbl2709270 |
Similar Items
-
CHEMOKINES CCL17 AND CCL22 IN SARCOIDOSIS
by: N. M. Lazareva, et al.
Published: (2021-10-01) -
Positive association between pruritus and high expression of CCL17, CCL22 and substance P in bullous pemphigoid lesions
by: Manman ZHANG, et al.
Published: (2022-12-01) -
Fulvic Acid Attenuates Atopic Dermatitis by Downregulating CCL17/22
by: Chenxi Wu, et al.
Published: (2023-04-01) -
Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer
by: Nasrollah Erfani, et al.
Published: (2015-07-01) -
CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy
by: Joanna Bogacka, et al.
Published: (2022-12-01)